Skip to Content
UW Health SMPH

Mark R. Albertini, MD close

Mark R. Albertini, MD
Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Mark Albertini is an associate professor (with tenure) of medicine at the University of Wisconsin (UW). Dr. Albertini is a nationally-known melanoma researcher who has led treatment efforts for patients with metastatic melanoma at the University of Wisconsin Paul P. Carbone Comprehensive Cancer Center since he joined the faculty in 1993. Dr. Albertini established the UW Carbone Cancer Center Comprehensive Melanoma Clinic in September of 1994 and is the leader of the UW Carbone Cancer Center Melanoma Disease-Oriented working group. Dr. Albertini has been awarded the Professionalism Award by the UW Department of Medicine Housestaff and has been selected for listing by the Best Doctors in America organization. Dr. Albertini has also served as Chief of Oncology at the William S. Middleton Memorial Veterans Hospital since January of 2003.


UW Health Clinics
Medical Oncology Clinic (608) 265-1700
(800) 323-8942
UW Carbone Cancer Center Map  |  Wayfinding
Melanoma Clinic (608) 265-1700
(800) 323-8942
UW Carbone Cancer Center Map

Languages Spoken
English
Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.

Professional Certifications and Education
Board Certification Internal Medicine
Medical Oncology
Fellowship UW Comprehensive Cancer Center
Residency University of Wisconsin Hospital and Clinics
Internship University of Wisconsin Hospital and Clinics
Medical School University of Vermont, 1984

Hospital Affiliations
Primary Affiliation(s) University of Wisconsin Hospital and Clinics
Secondary Affiliation(s) Veterans Hospital - Wm. S. Middleton Memorial

Research
The overall goal of Dr. Mark Albertini's research program is to provide an understanding of the immunobiology of human malignant melanoma as a means to develop effective treatment and monitoring strategies for patients with this disease. This goal is pursued with clinical and laboratory studies involving melanoma patients and with preclinical model systems to direct subsequent clinical studies. Dr. Albertini has been a mentor for clinical trainees with an interest in the care of melanoma patients, and Dr. Albertini has provided focused melanoma translational laboratory training to predoctoral and postdoctoral trainees in his research laboratory. Dr. Albertini has been a member of the Melanoma Committee in the Eastern Cooperative Oncology Group since 1994.

UW School of Medicine and Public Health
Department of Medicine